Given its shorter testing duration and potential to improve pregnancy outcomes, using library concentration to guide the transfer priority of embryos in fresh cycles could be considered.

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology

Selected as an Editor’s Choice from our March issue, this paper adds to the debate surrounding the existence of correlations between endometriosis, oocyte morphology and quality

doi.org/10.1016/j.rb...

1/3

#RBMOeditorsChoice #ClinicalAssistedReproductiveTechnology #Endometriosis

This new systematic review investigates whether gonadotrophin-releasing hormone agonist pretreatment has a positive effect on pregnancy outcomes in women with adenomyosis who were undergoing a frozen embryo transfer cycle.

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology

In this new Commentary article, former RBMO Chief Editor, Bart Fauser and Arie Franx outline how current outcome measures could detrimentally affect the way ART is practiced, and propose ways to improve such outcomes.

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology #ARToutcomes

This open access paper investigates the pain intensity of oocyte retrieval without anaesthesia, discussing techniques which may save costs and treatment time, and may also reduce anxiety in patients who are afraid of anaesthesia.

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology

This large multicenter cohort study indicated that between frozen embryo transfer (FET) may reduce the risk of monozygotic twinning (MZT) at the blastocyst stage.

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology #Blastocyst

This new narrative review examines the physiological and pathological roles of E2 in natural and ART cycles, emphasizing its impact on endometrial function, implantation, and pregnancy outcomes.

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology

A paper demonstrating that critical thinking and open debate are essential not only to science but also to improving the care we provide our patients.

Read the Commentary for free from issue 51.2

doi.org/10.1016/j.rb...

#RBMOcommentary #ClinicalAssistedReproductiveTechnology #PeerReview

This new review article compiles the literature on embryological-clinical classifications into a new system that more adequately defines all published female genitourinary malformations into six groups of anomalies

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology

The data presented in this paper suggest that progesterone priming may positively influence oocyte donation cycles while potentially offering a more patient-friendly and cost-effective option for donors.

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology #OocyteDonation

Published open access, this new study proposes a hypothetical mechanism through which progestin indirectly affects oocyte development, leading to a compensatory increase in mitochondrial gene expression in mGCs.

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology

The data presented in this new study supports the continued use of aromatase inhibitors for gonadotoxic treatment cycles, as IVF cycle outcomes and live birth rates are comparable to those for cycles with no adjuvant medication.

doi.org/10.1016/j.rb...

#ClinicalAssistedReproductiveTechnology

This new review article compiles the literature on embryological-clinical classifications into a new system that more adequately defines all published female genitourinary malformations into six groups of anomalies

https://doi.org/10.1016/j.rbmo.2024.104751

#ClinicalAssistedReproductiveTechnology